Liposomes and liposome-derived nanovesicles such as archaeosomes and virosomes have
become important carrier systems in vaccine development and the interest for liposome …

Cancer immunotherapy, as a paradigm shift in cancer treatment, has recently received
tremendous attention. The active cancer vaccination, immune checkpoint blockage (ICB) …

Natural cells have been explored as drug carriers for a long period. They have received
growing interest as a promising drug delivery system (DDS) until recently along with the …

Liposomes are closed bilayer structures spontaneously formed by hydrated phospholipids
that are widely used as efficient delivery systems for drugs or antigens, due to their capability …

Breakthroughs in materials engineering have accelerated the progress of immunotherapy in
preclinical studies. The interplay of chemistry and materials has resulted in improved …

Active anti-cancer immune responses depend on efficient presentation of tumor antigens
and co-stimulatory signals by antigen-presenting cells (APCs). Therapy with autologous …

The past decade has witnessed the explosive development of cancer immunotherapies.
Nevertheless, low immunogenicity, limited specificity, poor delivery efficiency, and off‐target …

T cells are often referred to as the 'guided missiles' of our immune system because of their
capacity to traffic to and accumulate at sites of infection or disease, destroy infected or …

Liposomes not only offer the ability to enhance drug delivery, but can effectively act as
vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and …

Cancer immunotherapy critically relies on the efficient presentation of tumor antigens to T-
cells to elicit a potent anti-tumor immune response aimed at life-long protection against …